AllysonJoyOceanMD

PubMed

• 12 citations
  Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.
  Pashtoon Murtaza Kasi, Manuel Hidalgo, Mehraneh D Jafari, Heather Yeo, Lea Lowenfeld
  Oncogene. 2023-10-01
• 570 citations
  Organoid profiling identifies common responders to chemotherapy in pancreatic cancer
  Hervé Tiriac, Pascal Belleau, Dannielle D. Engle, Dennis Plenker, Astrid Deschênes
  Cancer Discovery. 2018-05-31
• 1848 citations
  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
  Bruno Costa-Silva, Nicole M. Aiello, Allyson J. Ocean, Swarnima Singh, Haiying Zhang
  Nature Cell Biology. 2015-06-01

Journal Articles

• Phase II trial of bortezomib alone or in combinationwith irinotecan in patients with adenocarcinomaof the gastroesophageal junction or stomach  
  Allyson J. Ocean, Paul Christos, Joseph A. Sparano, Manish A. Shah, Rhonda K. Yantiss, Jonathan Cheng , Juan Lin, Michael Papetti, Dan Matulich, Felice Schnoll-Sussman..., Invest New Drugs, 1/1/2014
• Fractionated Radioimmunotherapy (RAIT) With 90Y-Clivatuzumab Tetraxetan (90Y-hPAM4) And Low-dose Gemcitabine Is Active In Advanced Pancreatic Cancer: A Phase I trial  
  Allyson J. Ocean, MD; Kenneth L. Pennington, MD; Michael J. Guarino, MD; Arif Sheikh, MD; Tanios Bekaii-Saab, MD; Aldo N. Serafini, MD; Daniel Lee, MD; Max W. Sung, MD..., Cancer, 1/8/2012
• Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach  
  Carlson K, Ocean AJ, Clinical Breast Cancer, 1/1/2011
• Isolated splenic metastasis from rectal carcinoma: a rare occurrence  
  Jain S, Munjal S, Yantiss RK, Sonoda T, Fahey TJ, Ruggiero JT, Anand A, Gersten , Goldsmith SJ, Ocean AJ, Case Reports in Oncology, 1/1/2011
• Phase II trial of the ribonucleotidereductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer  
  Allyson J. Ocean, Paul Christos, Joseph A. Sparano, Dan Matulich, Andreas Kaubish, Abby Siegel, Max Sung, Maureen M. Ward, Nancy Hamel, Igor Espinoza-Delgado, Yun Yen,..., Cancer Chemotherapy and Pharmacology, 1/28/2010
• A Phase I Trial of Oblimersen Sodium in Combination WithCisplatin and 5-Fluorouracil in Patients with Advanced Esophageal, Gastro-Esophageal Junction and Gastric Carci...  
  Rachel Raab, MD, Joseph A. Sparano, MD, Allyson J. Ocean, MD, Paul Christos,MPH, MS, Mark Ramirez, MD, Vincent Vinciguerra, MD, and Andreas Kaubisch, MD, American Journal of Clinical Oncology, 1/1/2010
• Phase II Study of Paclitaxel Plus the Protein Kinase C Inhibitor Bryostatin-1 in Advanced Pancreatic Carcinoma  
  Lam, AP, Sparano JA, Vinciguerra V, Ocean AJ, Christos P, Hochster H, Camacho F, Goel S, Mani S, Kaubisch A, American Journal of Clinical Oncology, 1/1/2010
• Cetuximab is Associated with Excessive Toxicity When Combined WithBevacizumab Plus mFOLFOX6 in Metastatic Colorectal Carcinoma  
  Allyson J. Ocean, Blase Polite, Paul Christos, Lisa Horvath, Anne Hamilton, Daniel Matulich, Helen X. Chen, Joseph A. Sparano, Hedy L. Kindler, Clinical Colorectal Cancer, 1/1/2010
• Colorectal Cancer Report: Trends and Treatment Options  
  Ocean, Allyson J., M.D., Women & Cancer, 1/1/2010
• Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma  
  Abby B. Siegel, Emil I. Cohen, Allyson Ocean, Deborah Lehrer, Alec Goldenberg, Jennifer J. Knox, Helen Chen, Sean Clark-Garvey, Alan Weinberg, John Mandeli, Paul Chris..., Journal of Clinical Oncology, 1/20/2008
• The Other Women’s Cancer: An Update on Screening, Diagnosis, and Treatment Options for Colorectal Cancer  
  Ocean, Allyson J., M.D., Women & Cancer, 1/1/2008
• Women Have Colons, Too: Colorectal Cancer Prevention, Screening, and Treatment Options  
  Ocean, Allyson J., M.D., Women & Cancer, 1/1/2006
• Chemotherapy-Induced Peripheral Neuropathy: Etiology and Emerging Therapies  
  Ocean, AJ, Journal of Supportive Care in Cancer, 1/16/2004
• Join now to see all

Books/Book Chapters

• Advances in Surgical Pathology: Colorectal Carcinoma and Tumors of the Veriform Appendix 
  Chapter: Targeted Therapies for the Treatment of Advanced Colorectal Carcinoma. 
  Page 255 - 266Ocean, Allyson J., M.D., Palmer, Romae, and Shah, Manish A., M.D.Editors: Rhonda K. Yantiss, MD.Lippincott Williams & Wilkins2014

Abstracts/Posters

• The incidence and impact of poor nutrition in gastrointestinal malignancies.
  Douglas Eric Guggenheim, Allyson J. Ocean, Elizabeta C. Popa, Amanda R Magli, Irene Karpenko, Paul J. Christos, Veronica A. Rosales, Erika Ocampo Florendo, Joseph T. R..., J Clin Oncol, 1/1/2013
• Effect of CTCAE v4 grading of hypertension on reported toxicity in advanced cancer patients receiving vascular endothelial growth factor (VEGF)-targeting agents.
  Naveed Hassan Akhtar, Beerinder Singh, Allyson J. Ocean, Irene Karpenko, Himisha Beltran, Elizabeta C. Popa, David M. Nanus, Manish A. Shah, Scott T. Tagawa, J Clin Oncol, 1/1/2013
• Phase I/II trial of intraperitoneal implantation of agarose-agarosemacrobeads (MB) containing mouse renal adenocarcinoma cells (RENCA) in patients (pts) with advanced ...
  Allyson J. Ocean, Tapan Parikh, Nathaniel Berman, Juliet Escalon, Manish A. Shah, Zoe Andrada, Eugene Akahoho, Janice M. Pogoda, George B. Stoms, Verula B Escobia, Jos..., J Clin Oncol, 1/1/2013
• A multicenter phase I study of intravenous administration of reolysin in combination with irinotecan/fluorouracil/leucovorin (FOLFIRI) in patients (pts) with oxaliplat...
  Allyson J. Ocean, Tanios S. Bekaii-Saab, Imran Chaudhary, Romae Palmer, Paul J. Christos, Alice Mercado, Erika O. Florendo, Veronica A. Rosales, Joseph T. Ruggiero, El..., J Clin Oncol, 1/1/2012
• Phase I/II study of 90Y-clivatuzumab tetraxetan (90Y-hPAM4) combined with gemcitabine (Gem) in advanced pancreatic cancer (APC): Final results.
  Allyson J. Ocean, Michael J. Guarino, Kenneth L. Pennington, Gregory M. Springett, Seza A Gulec, Tanios S. Bekaii-Saab, Alberto J. Montero, Edith P. Mitchell, John S. ..., J Clin Oncol, 1/1/2012
• Activity of fractionated radioimmunotherapy (RAIT) with 90Y clivatuzumabtetraxetan (90Y-hPAM4) plus gemcitabine (Gem) in advanced pancreatic cancer (APC): Final result...
  J Clin Oncol, 1/1/2012
• Therapeutic effects of fractionated radioimmunotherapy (RAIT) with clivatuzumabtetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC).
  A. J. Ocean, M. J. Guarino, K. L. Pennington, B.H. O’Neil, C.M.S. Rocha Lima, T.S. Bekaii-Saab, S.A.Gulec, D. V. Gold, W. A. Wegener, D. M. Goldenberg, Poster Presentation, Proc Gastrointestinal Cancers Symposium, 1/1/2011
• Treatment of advanced, epithelial-derived cancer (AEC) with intraperitoneal implantation of agarose-agarosemacrobeads (MB) containing mouse renal adenocarcinoma cells ...
  C.H. Keir, A. J. Ocean, T. J. Fahey, N. Berman, A. Wadke, L. Kelly-Rossini, M. J. Goldstein, D. B. Leeser, F. Michelassi, B. H. Smith, J Clin Oncol, 1/1/2011
• Activity of fractionated radioimmunotherapy with clivatuzumabtetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC).
  A. J. Ocean, M. J. Guarino, K. L. Pennington, A. J. Montero, T. Bekaii-Saab, S. A. Gulec, N. Teoh, D. V. Gold, W. A. Wegener, D. M. Goldenberg, J Clin Oncol, 1/1/2011
• Random assignment multicenter phase II study of modified docetaxel, cisplatin, fluorouracil (mDCF) versus DCF with growth factor support (GCSF) in metastatic gastroeso...
  M. A. Shah, R. Stoller, S. Shibata, M. Kemeny, B. Mehrotra, P. S. Ritch, A. J. Ocean, S. S. Krishnamurthi, C. A. Henderson, D. P. Kelsen, Poster Presentation, Proc Gastrointestinal Cancers Symposium, 1/1/2010
• Random assignment multicenter phase II study of modified docetaxel, cisplatin, fluorouracil (mDCF) versus DCF with growth factor support (GCSF) in metastatic gastroeso...
  M. A. Shah, R. Stoller, S. Shibata, M. Kemeny, B. Mehrotra, P. S. Ritch, A. J. Ocean, S. S. Krishnamurthi, C. A. Henderson, D. P. Kelsen., Proc Gastrointestinal Cancers Symposium, 1/1/2010
• Repeated treatment cycles of fractionated radioimmunotherapy (RAIT) combined with low-dose radiosensitizing gemcitabine (Gem) in advanced pancreatic cancer (APC).
  K. L. Pennington, M. J. Guarino, A. Sheikh, A. J. Ocean, A. N. Serafini, D. V. Gold, R. M. Sharkey, H. Horne, W. A. Wegener, D. M. Goldenberg, Proc Gastrointestinal Cancers Symposium, 1/1/2010
• Therapeutic effects of fractionated radioimmunotherapy (RAIT) with clivatuzumabtetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC).
  A. J. Ocean, M. J. Guarino, K. L. Pennington, B.H. O’Neil, C.M.S. Rocha Lima, T.S. Bekaii-Saab, S.A.Gulec, D. V. Gold, W. A. Wegener, D. M. Goldenberg, J Clin Oncol, 1/1/2010
• Repeated treatment cycles of fractionated radioimmunotherapy (RAIT) combined with low-dose radiosensitizing gemcitabine (Gem) in advanced pancreatic cancer (APC).
  K. L. Pennington, M. J. Guarino, A. Sheikh, A. J. Ocean, A. N. Serafini, D. V. Gold, R. M. Sharkey, H. Horne, W. A. Wegener, D. M. Goldenberg, Poster Presentation, Proc Gastrointestinal Cancers Symposium, 1/1/2010
• Therapeutic effects of fractionated radioimmunotherapy (RAIT) with clivatuzumabtetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC).
  A. J. Ocean, M. J. Guarino, K. L. Pennington, B.H. O’Neil, C.M.S. Rocha Lima, T.S. Bekaii-Saab, S.A.Gulec, D. V. Gold, W. A. Wegener, D. M. Goldenberg, Poster Presentation, Proc American Society of Clinical Oncology, 1/1/2010
• NCI 6254: A Phase II Study of Triapine (T) in combination with gemcitabine (G) in adenocarcinoma (ACA) of the biliary ducts (BD) and gall bladder (GB).
  M.J. Weissler, H.L. Kindler, Y. Yen, M. McNamara, D. Matulich, P.J. Christos, M. Mazumdar, I. Espinoza-Delgado, J. Sparano, A.J. Ocean, Poster Presentation- Proc Gastrointestinal Cancers Symposium, 1/1/2009
• NCI 6254: A Phase II Study of Triapine (T) in combination with gemcitabine (G) in adenocarcinoma (ACA) of the biliary ducts (BD) and gall bladder (GB).
  M.J. Weissler, H.L. Kindler, Y. Yen, M. McNamara, D. Matulich, P.J. Christos, M. Mazumdar, I. Espinoza-Delgado, J. Sparano, A.J. Ocean, Proc Gastrointestinal Cancers Symposium, 1/1/2009
• LE-SN38 for metastatic colorectal cancer after progression on oxaliplatin: results of CALGB 80402.
  A.J. Ocean, D. Niedzwiecki, J.N. Atkins, B. Parker, B. O’Neil, J.W.Lee, S. Wadler, R.M. Goldberg, Proc ASCO, 1/1/2008
• Recent results of phase II study of PS-341 (bortezomib) with or without irinotecan in patients (pts) with advanced gastric adenocarcinomas (AGA).
  A. J. Ocean, F. Schnoll-Sussman, X. E. Chen, R. Keresztes, S. Holloway, N. Matthews, K. O'Brien, P. Christos, M. Mazumdar, S. Wadler, Proc Gastrointestinal Cancers Symposium, 1/1/2007
• Phase II trial of FOLFOX6, bevacizumab and cetuximab in patients with Colorectal Cancer.
  Ocean, AJ, O’Brien, K., Lee, J., Matthews, N., Holloway, S., Christos, P., Kung, T.S., Kaubisch, A., Chen, H., Wadler, S., Poster Presentation, Proc ASCO, 1/1/2007
• Recent Results of phase II study of PS-341 (bortezomib) with or without irinotecan in patients (pts) with advanced gastric adenocarcinomas (AGA).
  Ocean, AJ, Schnoll-Sussman, F., Chen, X.E., Keresztes, R., Holloway, S., Matthews, N., O’Brien, K., Christos, P., Mazumdar, M., Wadler, S., Poster Presentation, Proc ASCO GI Cancer Symposium, 1/1/2007
• Phase II Trial of FOLFOX6, bevacizumab and cetuximab in patients with Colorectal Cancer.
  AJ. Ocean, K. O'Brien, J. Lee, N. Matthews, S. Holloway, P. Christos, T. S. Kung, A. Kaubisch, H. Chen, S. Wadler, Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings, 1/1/2007
• WadlerBevacizumab in unresectable hepatocellular carcinoma (HCC) for patients without metastasis and without invasion of the portal vein.
  J. D. Schwartz, M. Schwartz, D. Lehrer, E. Cohen, M. Sung, M. Kinkhabwala, A. Siegel, S. Holloway, A. Ocean, S., Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings, 1/1/2006
• Bevacizumab in unresectable hepatocellular carcinoma (HCC) for patients without metastasis and without invasion of the portal vein.
  J.D. Schwartz, M. Schwartz, M. Sung, D. Lehrer, E. Cohen, M. Kinkhabwala, S.B. Holloway, A. Siegel, A. Ocean, S. Wadler, Poster Presentation, Proc ASCO GI Cancer Symposium, 1/1/2006
• Bevacizumab in unresectable hepatocellular carcinoma (HCC) for patients without metastasis and without invasion of the portal vein.
  Schwartz, JD, Schwartz, M, Sung M, Lehrer, D, Cohen, E, Kinkhabwala, M, Holloway, S.B., Siegel, A, Ocean, A, Wadler, S, Proc Gastrointestinal Cancers Symposium, 1/1/2006
• Join now to see all

Lectures

• “Current Standard and Experimental Treatments in Pancreatic Cancer: Chemotherapy and Targeted Therapies.” 
  1/19/2011
• “Early Stage Colorectal Cancer: Reducing Risk of Recurrence.” 
  New York Presbyterian Hospital-Columbia - 1/13/2011
• “ClivatuzumabTetraxetan for the Therapy of Patients with Pancreatic Cancer.” 
  New York City, NY - 1/15/2010
• “Advances in Pancreatic Cancer” 
  Methodist Hospital, Brooklyn, NY - 1/10/2010
• Keynote Speaker, Pancreatic session 
  Dallas, TX - 1/15/2009
• Roche Oncology Training Class: Colorectal Cancer Treatment Background and Chemotherapy Pharmacology. 
  Nutley, NJ - 1/25/2008
• “Pancreatic Cancer Update 2008: Therapeutic Options and Research” 
  Lenox Hill Hospital, New York, NY - 1/19/2008
• Roche Oncology. 
  1/15/2008
• “Advances in Colorectal Cancer” 
  1/6/2008
• “Refining the Regimen: Update on Non-Small Cell Lung Cancer Treatment." 
  East Orange General Hospital, East Orange, NJ - 1/27/2007
• Regional Advancing the Treatment of Gastrointestinal Cancers Academic Advisory Board. 
  Washington, DC - 1/26/2007
• “Therapeutic Options in Pancreatic Cancer.” 
  New York, NY - 1/23/2007
• “Therapeutic Options in Pancreatic Cancer and Research Update.” 
  St. Vincent’s Comprehensive Cancer Center. New York, NY - 1/2/2007
• “Emerging Treatment Modalities for Colorectal Cancer: Chemotherapy and Targeted Therapy Options.” 
  Weill Medical College of Cornell University, New York, NY - 1/2/2007
• “Phase II FOLFOX, Bevacizumab, and Cetuximab in Colon Cancer.” 
  New York, NY - 1/19/2006
• “Emerging Trends in Oncology: Update on Pancreatic and Gastric Cancer, ASCO 2006.” 
  New York, NY - 1/15/2006
• Recent Advances in the First-Line Treatment of Patients with Metastatic Colorectal Cancer: The Role of Avastin (Bevacizumab). 
  1/10/2006
• “New Approaches to Lung Cancer: Translating Clinical Research into Clinical Practice.” 
  St. Agnes Hospital, Baltimore, MD - 1/9/2006
• Training Class of Pharmaceutical Representatives of Sanofi-Aventis 
  New Jersey, Jun 27, 2006 - 1/8/2006
• “Emerging Treatment Options in Colorectal Cancer.” 
  1/17/2005
• Join now to see all

Other

• Good Morning America presentation 
  Ocean AJ
  http://abcnews.go.com/video/playerIndex?id=7167408
  1/25/2009
• Larry King Live presentation 
  Ocean AJ
  http://www.cnn.com/video/#/video/health/2009/05/19/lkl.farrahs.story.long.cnn?iref=videosearch
  1/19/2009
• “What makes pancreatic cancer so deadly?”, Online Interview 
  Ocean AJ, The Scientific American
  1/25/2008
• NY1 presentation 
  Ocean AJ
  http://www.ny1.com/Default.aspx?ArID=86561
  1/1/2008
• TV Segment “CNN: Wolf Blitzer’s Situation Room”, re: Tony Snow’s Colon Cancer Recurrence 
  Ocean AJ, Fox 5, Associated Press, Reuters and Bloomberg News
  1/1/2007
• Medical Advisory Board, Oral Chemotherapy Advisors Video Webcast Production. 
  Ocean AJ, Sponsor: Roche Laboratories, Inc.
  http://www.oralchemoadvisor.com
  Nutley, NJ - 1/26/2006
• Join now to see all